Conclusion
We found that neonates in utero exposed to BDZs had a statistically
significant lower gestational age of -3.2 days compared to neonates not
exposed to BDZs in mothers with mental disorders. This difference seems
not clinically relevant. We also found that the use of BDZs during
pregnancy is associated with prolonged psychiatric care after delivery
concerning the mother. We found no differences between exposed or none
exposed to BDZs regarding birth weight, the number of congenital
malformations, APGAR score, and the need for prolonged psychiatric
care.